As reported by the Wall Street Journal in its’ article entitled "How Pfizer Set the Cost of its New Drug at $9,850," Pfizer determined that:________.
A. a price below $10,000 (or its determined price of $9,850) for its new drug Ibrance would result in a rapid increase in its marginal costs.
B. a price below $10,000 (or its determined price of $9,850) for its new drug Ibrance would result in a decline in its (total sale) revenues reflecting a price elasticity greater than one (in absolute value) for prices less than $10,000.
C. a price above $10,000 (or its determined price of $9,850) for its new drug Ibrance would result in a decline in its (total sale) revenues reflecting a price elasticity less than one (in absolute value) for prices exceeding $10,000.
D. a price above $10,000 (or its determined price of $9,850) for its new drug Ibrance would result in a decline in its (total sale) revenues reflecting a price elasticity greater than one (in absolute value) for prices exceeding $10,000.